Filing Details
- Accession Number:
- 0001213900-24-015446
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-20 18:36:56
- Reporting Period:
- 2024-02-15
- Accepted Time:
- 2024-02-20 18:36:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1821586 | Moonlake Immunotherapeutics | MLTX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1920509 | Jorge Silva Da Santos | C/O Moonlake Immunotherapeutics Dorfstrasse 29 Zug V8 6300 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Ordinary Shares, Par Value $0.0001 Per Share | Disposition | 2024-02-15 | 20,000 | $60.18 | 3,147,554 | No | 4 | S | Direct | |
| Class A Ordinary Shares, Par Value $0.0001 Per Share | Disposition | 2024-02-16 | 20,000 | $60.15 | 3,127,554 | No | 4 | S | Direct | |
| Class A Ordinary Shares, Par Value $0.0001 Per Share | Disposition | 2024-02-20 | 20,000 | $57.44 | 3,107,554 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on October 17, 2023.
- The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $58.185 to $63.95. Upon request by the staff of the U.S. Securities and Exchange Commission (the "Commission"), the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $59.335 to $61.17. Upon request by the staff of the Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $55.115 to $59.21. Upon request by the staff of the Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
